The exocrine pancreatic insufficiency (epi) therapeutics and diagnostics market size is expected to see strong growth in the next few years. It will grow to $7.67 billion in 2028 at … Continue reading Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Global Market 2024 – By Size, Share, Trends, Demand, Forecast To 2033 | Pfizer Inc., Merck & Co. Inc., Janssen Pharmaceuticals Inc